Effect of RevX solution adjunct to standard therapy in a patient with metastatic lung adenocarcinoma: A case report

Effect of RevX solution adjunct to standard therapy in a patient with metastatic lung adenocarcinoma: A case report

Cheng-Jui Lin, MD, PhD 1,2,3

1Division of Nephrology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan. 2Department of Medicine, Mackay Medical College, New Taipei City, Taiwan. 3Mackay Junior College of Medicine, Nursing and Management, Taipei, Taiwan.

RevX solution is a liquid fermented grain extract obtained through a unique extraction technology, and its ingredients contain phytosterols, sulfonamides, organic acids, and anti-inflammatory substances. The adjunct treatment of RevX for lung adenocarcinoma has not yet been surveyed in vitro or in vivo experiments. A 71-year-old woman was diagnosed with lung adenocarcinoma. She underwent the targeted therapy and continually took the RevX solution (3 to 5 ml per day). Sixteen months after diagnosis and targeted therapy, multiple lung metastases appeared. After the second-line targeted therapy and wedge resection for 16 months, the patient was still alive. The distinct improvement of hypodynamia and fewer complication was found during targeted therapy treatment complemented with the RevX solution for longer than 4 years. Thus, the RevX solution might potentially be an adjuvant therapy for patients with metastatic lung adenocarcinoma.

Keywords: Metastatic lung adenocarcinoma, traditional Chinese medicine, RevX solution

Free Full-text PDF

How to cite this article:

Cheng-Jui Lin. Effect of RevX solution adjunct to standard therapy in a patient with metastatic lung adenocarcinoma: A case report. International Journal of Case Reports, 2021, 5:238. DOI: 10.28933/ijcr-2021-08-1806


1. Bade BC, Dela Cruz CS. Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clin Chest Med. 2020;41:1-24.
2. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68: 394–424.
3. World Health Organization. Cancer fact sheets, lung cancer. 2018. Available at: http://gco.iarc.fr/ today/fact-sheets-cancers. Accessed August 8, 2021.
4. Liu ZL, Zhu WR, Zhou WC, et al. Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: a systematic review and meta-analysis. J Integr Med. 2014;12:346-58.
5. Yang XB, Wu WY, Long SQ, et al. Effect of gefitinib plus Chinese herbal medicine (CHM) in patients with advanced non-small-cell lung cancer: a retrospective case-control study. Complement Ther Med. 2014;22:1010-8.
6. Tang WR, Yang SH, Yu CT, et al. Long-Term Effectiveness of Combined Treatment with Traditional Chinese Medicine and Western Medicine on the Prognosis of Patients with Lung Cancer. J Altern Complement Med. 2016;22:212-22.
7. Li CL, Hsia TC, Li CH, et al. Adjunctive Traditional Chinese Medicine Improves Survival in Patients With Advanced Lung Adenocarcinoma Treated With First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs): A Nationwide, Population-Based Cohort Study. Integr Cancer Ther. 2019 ;18:1534735419827079.
8. Kuo YT, Chang TT, Muo CH, et al. Use of Complementary Traditional Chinese Medicines by Adult Cancer Patients in Taiwan: A Nationwide Population-Based Study. Integr Cancer Ther. 2018;17:531-541.
9. Li L, Ying XJ, Sun TT, et al. Overview of methodological quality of systematic reviews about gastric cancer risk and protective factors. Asian Pac J Cancer Prev. 2012;13:2069-79.
10. La Marca M, Beffy P, Pugliese A, et al. Fermented wheat powder induces the antioxidant and detoxifying system in primary rat hepatocytes. PLoS One. 2013;8:e83538.
11. Pyo YH, Seong KS. Effects of Monascus-fermented grain extracts on plasma antioxidant status and tissue levels of ubiquinones and α-tocopherol in hyperlipidemic rats. Food Chem. 2013;141:428-35.
12. Tatewaki N, Bhilwade HN, Nishida H, et al. Manipulation of DNA damage checkpoint signaling in cancer cells by antioxidant biofactor (AOB). Food Funct. 2013;4:63-73.
13. Zaroug M, Orhan IE, Senol FS, et al. Comparative antioxidant activity appraisal of traditional Sudanese kisra prepared from two sorghum cultivars. Food Chem. 2014;156:110-6.
14. Wu HC, Chen ST, Chang JC, et al. Radical Scavenging and Antiproliferative Effects of Cordycepin-Rich Ethanol Extract from Brown Rice-Cultivated Cordyceps militaris (Ascomycetes) Mycelium on Breast Cancer Cell Lines. Int J Med Mushrooms. 2019;21:657-669.
15. Liu J, Wang H, Liu X, et al. Chinese liquor extract attenuates oxidative damage in HepG2 cells and extends lifespan of Caenorhabditis elegans. Food Sci Nutr. 2020;8:3164-3172.
16. Das G, Heredia JB, de Lourdes Pereira M, et al. Korean traditional foods as antiviral and respiratory disease prevention and treatments: A detailed review. Trends Food Sci Technol. 2021 Jul 30. doi: 10.1016/j.tifs.2021.07.037.
17. Alkhatib A, Tsang C, Tiss A, et al. Functional Foods and Lifestyle Approaches for Diabetes Prevention and Management. Nutrients. 2017;9:1310.
18. Ernst E, Pittler MH. Assessment of therapeutic safety in systematic reviews: literature review. BMJ. 2001;323(7312):546.

Terms of Use/Privacy Policy/ Disclaimer/ Other Policies:
You agree that by using our site, you have read, understood, and agreed to be bound by all of our terms of use/privacy policy/ disclaimer/ other policies (click here for details). This site cannot and does not contain professional advice. The information on this site is provided for general informational and educational purposes only and is not a substitute for professional advice. Accordingly, before taking any actions based upon such information, we encourage you to consult with the appropriate professionals. We do not provide any kind of professional advice. The use or reliance of any information contained on this site or our mobile application is solely at your own risk. Under no circumstance shall we have any liability to you for any loss or damage of any kind incurred as a result of the use of the site or our mobile application or reliance on any information provided on the site and our mobile application. We may publish articles without peer-review. Published articles of authors are open access. Authors hold the copyright and retain publishing rights without restrictions. Authors are solely responsible for their articles published in our journals. Publication of any information in authors’ articles does not constitute an endorsement by us. We make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability or completeness of any information that authors provided. more..

CC BY 4.0
This work and its PDF file(s) are licensed under a Creative Commons Attribution 4.0 International License.